JIUYUAN GENE (02566) repurchased 266,600 shares for HK$1,545,700 on October 13.
JIUYUAN GENE (02566) announced that on October 13, 2026, it repurchased 266,600 shares for HK$1,545,700.
JIUYUAN GENE (02566) announced that on October 13, 2026, it repurchased 266,600 shares for HK$1.5457 million.
Related Articles
Services and wealth management businesses become key "engine"! Citigroup (C.US) Q3 net profit surges 40% year-over-year, EPS beats expectations.
BAMA TEA (06980) repurchased 20,000 shares for HK$540,300 on October 13.
Hunan Warrant Pharmaceutical (688799.SH) subsidiary's chemical API terbutaline sulfate approved for marketing.
Services and wealth management businesses become key "engine"! Citigroup (C.US) Q3 net profit surges 40% year-over-year, EPS beats expectations.
BAMA TEA (06980) repurchased 20,000 shares for HK$540,300 on October 13.
Hunan Warrant Pharmaceutical (688799.SH) subsidiary's chemical API terbutaline sulfate approved for marketing.
